Cargando…

Propensity score analysis of radical proctectomy versus organ preservation using contact X-ray brachytherapy for rectal cancer

INTRODUCTION: Radical proctectomy (RP-TME) with neo adjuvant chemoradiotherapy (nCRT) remains the standard treatment for T2-T3 rectal cancer. Organ preservation (OP) using CRT and a “watch and wait” strategy (W&W) is a field of research. Planned organ preservation can be proposed for early T1-T3...

Descripción completa

Detalles Bibliográficos
Autores principales: Gerard, Jean-Pierre, Montagne, Lucile, Thamphya, Brice, Doyen, Jerôme, Schiappa, Renaud, Benezery, Karene, Gourgou, Sophie, Dejean, Catherine, Hannoun-Levi, Jean-Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791854/
https://www.ncbi.nlm.nih.gov/pubmed/35118202
http://dx.doi.org/10.1016/j.ctro.2021.12.007
_version_ 1784640275549782016
author Gerard, Jean-Pierre
Montagne, Lucile
Thamphya, Brice
Doyen, Jerôme
Schiappa, Renaud
Benezery, Karene
Gourgou, Sophie
Dejean, Catherine
Hannoun-Levi, Jean-Michel
author_facet Gerard, Jean-Pierre
Montagne, Lucile
Thamphya, Brice
Doyen, Jerôme
Schiappa, Renaud
Benezery, Karene
Gourgou, Sophie
Dejean, Catherine
Hannoun-Levi, Jean-Michel
author_sort Gerard, Jean-Pierre
collection PubMed
description INTRODUCTION: Radical proctectomy (RP-TME) with neo adjuvant chemoradiotherapy (nCRT) remains the standard treatment for T2-T3 rectal cancer. Organ preservation (OP) using CRT and a “watch and wait” strategy (W&W) is a field of research. Planned organ preservation can be proposed for early T1-T3 using contact X-ray brachytherapy (CXB). We compared the oncological outcomes of both approaches using a propensity score matched-cohort analysis. MATERIAL AND METHODS: For comparative analyses between patients with nCRT + RP-TME and patients with CXB + CRT, propensity scores were calculated with logistic regression and multiple imputations for missing data. The variables included in the propensity score model were PS status, T-N stage and rectal circumference extension. Patients were matched 1:1 using the nearest neighbor method with a 0.1 caliper restriction. The 5-year Cancer Specific survival was the primary end point. RESULTS: The Accord 12 phase III trial included 584 patients who treated with nCRT + RP-TME. The CXB cohort included 71 patients with a planned OP. To select OP patient candidate, T4, tumor with extension >66% circumference were eliminated and only patients treated with CXB + CRT were analyzed in the CXB cohort resulting in a total of 374 patients. A one to one paired cohort with 36 patients in each group was derived. These two cohorts were well matched for all confounding factors except for age. The 5-year cancer specific rate showed no significant difference between the two groups (89% in Accord 12 vs 82% in CXB; p = 0.84). At 5 years, rate of metastasis (15% vs 22%, p = 0.54) showed no significant difference. In the CXB group 33/36 patients preserved their rectum. CONCLUSION: The organ preservation strategy using CXB boost yielded a 5-year cancer specific survival rate similar to patients treated with RP-TME. In selected early T2-3 rectal adenocarcinoma an organ preservation strategy could be offered as a reasonable option.
format Online
Article
Text
id pubmed-8791854
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-87918542022-02-02 Propensity score analysis of radical proctectomy versus organ preservation using contact X-ray brachytherapy for rectal cancer Gerard, Jean-Pierre Montagne, Lucile Thamphya, Brice Doyen, Jerôme Schiappa, Renaud Benezery, Karene Gourgou, Sophie Dejean, Catherine Hannoun-Levi, Jean-Michel Clin Transl Radiat Oncol Article INTRODUCTION: Radical proctectomy (RP-TME) with neo adjuvant chemoradiotherapy (nCRT) remains the standard treatment for T2-T3 rectal cancer. Organ preservation (OP) using CRT and a “watch and wait” strategy (W&W) is a field of research. Planned organ preservation can be proposed for early T1-T3 using contact X-ray brachytherapy (CXB). We compared the oncological outcomes of both approaches using a propensity score matched-cohort analysis. MATERIAL AND METHODS: For comparative analyses between patients with nCRT + RP-TME and patients with CXB + CRT, propensity scores were calculated with logistic regression and multiple imputations for missing data. The variables included in the propensity score model were PS status, T-N stage and rectal circumference extension. Patients were matched 1:1 using the nearest neighbor method with a 0.1 caliper restriction. The 5-year Cancer Specific survival was the primary end point. RESULTS: The Accord 12 phase III trial included 584 patients who treated with nCRT + RP-TME. The CXB cohort included 71 patients with a planned OP. To select OP patient candidate, T4, tumor with extension >66% circumference were eliminated and only patients treated with CXB + CRT were analyzed in the CXB cohort resulting in a total of 374 patients. A one to one paired cohort with 36 patients in each group was derived. These two cohorts were well matched for all confounding factors except for age. The 5-year cancer specific rate showed no significant difference between the two groups (89% in Accord 12 vs 82% in CXB; p = 0.84). At 5 years, rate of metastasis (15% vs 22%, p = 0.54) showed no significant difference. In the CXB group 33/36 patients preserved their rectum. CONCLUSION: The organ preservation strategy using CXB boost yielded a 5-year cancer specific survival rate similar to patients treated with RP-TME. In selected early T2-3 rectal adenocarcinoma an organ preservation strategy could be offered as a reasonable option. Elsevier 2022-01-06 /pmc/articles/PMC8791854/ /pubmed/35118202 http://dx.doi.org/10.1016/j.ctro.2021.12.007 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Gerard, Jean-Pierre
Montagne, Lucile
Thamphya, Brice
Doyen, Jerôme
Schiappa, Renaud
Benezery, Karene
Gourgou, Sophie
Dejean, Catherine
Hannoun-Levi, Jean-Michel
Propensity score analysis of radical proctectomy versus organ preservation using contact X-ray brachytherapy for rectal cancer
title Propensity score analysis of radical proctectomy versus organ preservation using contact X-ray brachytherapy for rectal cancer
title_full Propensity score analysis of radical proctectomy versus organ preservation using contact X-ray brachytherapy for rectal cancer
title_fullStr Propensity score analysis of radical proctectomy versus organ preservation using contact X-ray brachytherapy for rectal cancer
title_full_unstemmed Propensity score analysis of radical proctectomy versus organ preservation using contact X-ray brachytherapy for rectal cancer
title_short Propensity score analysis of radical proctectomy versus organ preservation using contact X-ray brachytherapy for rectal cancer
title_sort propensity score analysis of radical proctectomy versus organ preservation using contact x-ray brachytherapy for rectal cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791854/
https://www.ncbi.nlm.nih.gov/pubmed/35118202
http://dx.doi.org/10.1016/j.ctro.2021.12.007
work_keys_str_mv AT gerardjeanpierre propensityscoreanalysisofradicalproctectomyversusorganpreservationusingcontactxraybrachytherapyforrectalcancer
AT montagnelucile propensityscoreanalysisofradicalproctectomyversusorganpreservationusingcontactxraybrachytherapyforrectalcancer
AT thamphyabrice propensityscoreanalysisofradicalproctectomyversusorganpreservationusingcontactxraybrachytherapyforrectalcancer
AT doyenjerome propensityscoreanalysisofradicalproctectomyversusorganpreservationusingcontactxraybrachytherapyforrectalcancer
AT schiapparenaud propensityscoreanalysisofradicalproctectomyversusorganpreservationusingcontactxraybrachytherapyforrectalcancer
AT benezerykarene propensityscoreanalysisofradicalproctectomyversusorganpreservationusingcontactxraybrachytherapyforrectalcancer
AT gourgousophie propensityscoreanalysisofradicalproctectomyversusorganpreservationusingcontactxraybrachytherapyforrectalcancer
AT dejeancatherine propensityscoreanalysisofradicalproctectomyversusorganpreservationusingcontactxraybrachytherapyforrectalcancer
AT hannounlevijeanmichel propensityscoreanalysisofradicalproctectomyversusorganpreservationusingcontactxraybrachytherapyforrectalcancer